International Centre For Genetic Engineering And Biotechnology

New Delhi, DL Doing business as Icgeb

UEI
DJZMN7DK37S8
CAGE
2320Y
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Other Not For Profit Organization
Entity structure
International Organization
SAM.gov registration date
Physical address
INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB, Aruna Asaf Ali Marg, Jawaharlal Nehru University, New Delhi, Delhi 110067, India
Website
icgeb.org
Founded
1983
Employees
251-1K
Estimated annual revenue
$50M-$100M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
The Washington University Scope of Work - Sharma lab – ICGEB The overall goal of this study is to identify small molecule inhibitors with appropriate potency, selectivity, and… R01AI143857 $54,000
The Washington University Scope of Work - Sharma lab – ICGEB The overall goal of this study is to identify small molecule inhibitors with appropriate potency, selectivity, and… R01AI143857 $54,000

Similar vendors

About the company

Here is a detailed two paragraph summary on Icgeb:

The International Center for Genetic Engineering and Biotechnology (Icgeb) is an international organization that provides research and development services focused on biotechnology and genetic engineering. Based on past federal grants, Icgeb supports projects related to developing treatments for infectious diseases.

Icgeb has received multiple federal subaward grants to provide biochemical testing and analysis services in support of developing small molecule inhibitors to treat toxoplasmosis. These services were provided under grants from the National Institutes of Health to prime grantee The Washington University. Specifically, Icgeb conducted enzymology studies and in vitro compound testing to identify inhibitors targeting the parasite enzyme phenylalanyl-tRNA synthetase across multiple grant awards. This included assessing potency and selectivity of compounds by testing inhibition against the Toxoplasma gondii enzyme, mutant variants, the human enzyme, and the Plasmodium falciparum malarial enzyme. The goal across these awards was to identify safe and effective drug candidates to cure chronic toxoplasmosis infections.

Quick answers

Is International Centre For Genetic Engineering And Biotechnology registered in SAM.gov?

Yes. International Centre For Genetic Engineering And Biotechnology's SAM.gov registration is active through February 9, 2027.

On GovTribe

See International Centre For Genetic Engineering And Biotechnology's full federal record

  • Similar vendors